Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose for postprandial hypotension with abnormal glucose metabolism
ChiCTR-IPR-15005996Phase 4Not yet recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Feb 2015
- Modality
- Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of acarbose in Postprandial hypotension (PPH) (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: Blood pressure, Heart rate and 5 more. Planned start Feb 2015; status: not yet recruiting.
02
Drugs
acarbose
03
Conditions
Postprandial hypotension (PPH)
Beyond the preview
Go deeper on ChiCTR-IPR-15005996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15005996.